Generics BulletinThe UK Medicines and Healthcare products Regulatory Agency has approved Biocon Biologics’ two denosumab biosimilars. Set to be marketed under the name Vevzuo, referencing Amgen’s Xgeva brand, the bios
Generics BulletinGedeon Richter feels its General Medicines division is “unfairly neglected” and “deserves a lot more attention and credit than we tend to give it,” as the Hungarian firm looks to add to reported 12% f
Generics BulletinAdalvo and Gedeon Richter have announced a global co-development deal for injectable semaglutide, that will see the firms pursue launches around the world in the potentially lucrative GLP-1 obesity ma
Generics BulletinFour biosimilars sponsors – Biocon Biologics, Gedeon Richter, Mabxience and Zentiva – have each received dual positive opinions from the European Medicines Agency’s Committee for Medicinal Products fo